Want to join the conversation?
Marc Goodman of UBS probes on Proair & Flonase & about the reason why Proair cannot be launched in 2016. $PRGO CEO John Hendrickson said the new products could still hit in the year, but they are not planned. Flonase is in the company's plan. Proair launch was planned at the end of CY16, but are moving out of the year seeing the dynamics.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?